These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9879418)

  • 1. Allergen-specific immunotherapy for allergic rhinitis: a new insight into its clinical efficacy and mechanism.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():178-90. PubMed ID: 9879418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen specific immunotherapy: new approaches].
    Tay F; Kündig TM; Senti G
    Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic rhinitis and its impact on asthma update: allergen immunotherapy.
    Passalacqua G; Durham SR;
    J Allergy Clin Immunol; 2007 Apr; 119(4):881-91. PubMed ID: 17418661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
    Nieminen K; Laaksonen K; Savolainen J
    Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for rhinitis.
    Malling HJ
    Curr Allergy Asthma Rep; 2003 May; 3(3):204-9. PubMed ID: 12662468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
    Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
    Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 12. Sublingual immunotherapy for allergic rhinitis.
    Wilson DR; Torres LI; Durham SR
    Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN; Galip N; Cobanoglu N
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Kato A; Masamoto T; Sakamoto H; Yamada K
    Scand J Immunol; 1998 Feb; 47(2):167-78. PubMed ID: 9496694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific immunotherapy for allergic rhinitis. Current methods and innovative developments].
    Pfaar O; Klimek L
    HNO; 2008 Aug; 56(8):764-75. PubMed ID: 18668217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.